Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Pettengell, R; Johnson, H E; Lugtenburg, P J; Salar Silvestre, A; Dührsen, U; Rossi, F G; Schwenkglenks, M; Bendall, K; Szabo, Z; Jaeger, U (2012). Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma. Supportive Care in Cancer, 20(3):647-652.

Johnsen, H E; Haioun, C; Lugtenburg, P J; Salar, A; Jaeger, U; Pettengell, R; Rossi, Fg; Verhoef, G; Schwenkglenks, M; Bendall, K; Duehrsen, U (2012). The importance of G-CSF prophylaxis in R-CHOP-14 therapy for diffuse large B-cell lymphoma in routine clinical practice. Leukemia and Lymphoma, 53(5):982-984.

Haioun, C; Salar, A; Pettengell, R; Johnsen, H E; Duehrsen, U; Rossi, F G; Verhoef, G; Schwenkglenks, M; Jaeger, U; Hamilton, L; Pujol, B; Lugtenburg, P J (2011). Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study. Leukemia and Lymphoma, 52(5):796-803.

Pfreundschuh, M; Kuhnt, E; Trümper, L; Osterborg, A; Trneny, M; Shepherd, L; Gill, D S; Walewski, J; Pettengell, R; Jaeger, U; Zinzani, P L; Shpilberg, O; Kvaloy, S; de Nully Brown, P; Stahel, R; Milpied, N; López-Guillermo, A; Poeschel, V; Grass, S; Loeffler, M; Murawski, N (2011). CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncology, 12(11):1013-1022.

This list was generated on Sun Sep 24 09:42:48 2017 CEST.